Mice with a targeted mutation of the Hoxa10 gene demonstrate uterine factor infertility. It is unclear if the defect in the uterine environment arises due to the absence of Hoxa10 expression during embryonic development or in the adult. We have recently demonstrated that HOXA10 expression in human endometrium rises dramatically at the time of implantation, suggesting maternal expression of Hoxa10/HOXA10 may be essential to the process. To assess the importance of maternal Hoxa10 expression, the uteri of day 2 pregnant mice were injected with a DNA/liposome complex containing constructs designed to alter maternal Hoxa10 expression before implantation. Transfection with a Hoxa10 antisense oligodeoxyribonucleotide significantly decreased the number
Introduction
The molecular mechanisms responsible for appropriate endometrial development and receptivity to implantation are poorly understood. 1 Hox genes are leading candidates for regulating differentiation of the endometrium in preparation for embryonic implantation. Hox genes are transcriptional regulators that have an important role in embryonic development. 2, 3 They assign the correct identity to undifferentiated body segments along several developmental axes. 4 Four genes of the Hoxa cluster, Hoxa9, Hoxa10, Hoxa11 and Hoxa13 are typically expressed in the developing reproductive system of the mouse. 5 Hox genes are typically expressed only during embryogenesis and their role in this process has been well characterized. However, we have previously shown that Hoxa genes demonstrate persistent adult expression in both the mouse and human female reproductive tract. 5 It is possible that the continued expression of these Hoxa genes allows the reproductive tract to maintain developmental plasticity and to differentiate appropriately during each menstrual cycle and throughout pregnancy.
Female mice with a targeted mutation of Hoxa10 demonstrate uterine factor infertility. 6 These mice ovulate normally and produce normal embryos. However, the uteri of Hoxa10-deficient mice will not support the implantation of either their own or wild-type embryos.
of implantation sites. Transfection with a plasmid which constitutively expresses Hoxa10 optimized survival of implanted embryos resulting in increased litter size. These results demonstrate that maternal Hoxa10 expression is essential for implantation and is the first report of the maternal alteration of a gene known to affect implantation specifically. We also demonstrate that DNA/liposome complexes containing the same Hoxa10 constructs that alter fertility in mice, can affect Hoxa10 expression in a human endometrial cell line. Alteration of human endometrial HOXA10 via liposome-mediated gene transfection is a potential contraceptive agent or fertility treatment. Gene Therapy (2000) 7, 1378-1384.
Hoxa10/HOXA10 is expressed in both the embryonic and adult endometrium of mice and humans. 5 In humans, we have previously demonstrated a dynamic expression pattern of HOXA10 in the endometrium throughout the menstrual cycle; HOXA10 expression rises significantly in the mid-secretory phase, the time of implantation. 7 The endometrium undergoes complex structural and functional changes during each menstrual cycle to allow successful implantation and subsequently to support the embryo through effective placentation. It has been proposed that the implantation defect seen in Hoxa 10-deficient mice is due to an abnormality in the embryonic development of the reproductive tract. 6 However, the continued expression of HOXA10 in the adult endometrium may regulate the cyclic structural and functional changes of this tissue in a manner analogous to embryonic development. The menstrual cycle-specific pattern of HOXA10 in human endometrium suggests that maternal Hoxa10/HOXA10 may be necessary for implantation.
Here we demonstrate that maternal Hoxa10 expression in the endometrium is essential for implantation. We use liposome-mediated gene transfaction 8, 9 to either block maternal Hoxa10 expression with a Hoxa10 antisense oligonucleotide or to increase maternal Hoxa10 expression with a plasmid that constitutively expresses Hoxa10. These experiments demonstrate that manipulation of adult Hoxa10 expression significantly affects fertility. This is the first time that gene transfection of the adult uterine endometrium has been shown to affect successfully a gene necessary for implantation. We have previously shown that, based on the rise in HOXA10 expression at the time of implantation, maternal HOXA10 is probably similarly required for this process in women. 7, 10 The alteration of human HOXA10 expression in the adult endometrium is a potential contraceptive agent or fertility treatment.
Results

Transfection of uterine endometrium
The ability of a DNA/liposome complex to transfect endometrial cells was demonstrated by transfecting both Ishikawa cells and mouse endometrium in vivo with pcDNA3.1(+)/LacZ. Ishikawa cells are a well differentiated cell line that express estrogen and progesterone receptors, 11 and are the best available model of endometrium. 
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To demonstrate that endometrium could also be transfected in vivo, a DNA/liposome complex containing pcDNA3.1(+)/LacZ was injected into the lumen of each uterine horn. Forty-eight hours later, the time of implantation, the uteri were sectioned and stained with X-gal for 24 h. Figure 2a shows murine endometrium transfected with pcDNA3.1(+)/LacZ and subsequently stained with X-gal. One hundred percent of glandular cells and 10% of stromal cells stained blue. Sections of mouse uterus transfected with control DNA and then treated with X-gal demonstrated minimal or absent staining (Figure 2b ). Serial sections from proximal to distal uterus revealed uniform results.
Decreased Hoxa10 expression after transfection with a Hoxa10 antisense oligonucleotide To determine that Hoxa10 expression can be manipulated in endometrial cells using a Hoxa10 antisense oligodeoxyribonucleotide, Ishikawa cells were transfected with a DNA/liposome complex containing a Hoxa10 antisense oligonucleotide, complementary to the translation start site of Hoxa10. This sequence is conserved in the mouse and human. A cell culture model was used due to the small amount of endometrial tissue per mouse and relatively low abundance of Hoxa10 protein that make these experiments impractical in vivo. HOX gene expression in Ishikawa cells is well characterized and has been demonstrated to be regulated as in the endometrium. 7, 13 Following transfection, cellular RNA and protein were extracted and Northern and Western analyses performed.
Levels of Hoxa10 mRNA were compared between cells transfected with either a Hoxa10 antisense oligonucleotide or a missense control oligonucleotide using Northern blot analysis. The values obtained for Hoxa10 were normalized to G3PDH. No change in Hoxa10 mRNA was seen in Ishikawa cells transfected with the Hoxa10 antisense oligonucleotide compared with Hoxa10 mRNA in cells transfected with a control oligonucleotide, suggesting normal transcription of Hoxa10 in the presence of the Hoxa10 antisense oligonucleotide (Figure 3a) .
Levels of Hoxa10 protein were decreased in cells trans- Transfection of mouse endometrium with a HOXA10 antisense oligonucleotide reduced implantation rates In order to block the maternal expression of Hoxa10 in mice that have normal Hoxa10 expression during embryogenesis, the antisense oligonucleotide previously described was used to transfect the endometrium of mice. A DNA/liposome complex containing the Hoxa10 antisense oligonucleotide was injected into the base of each uterine lumen 30-60 h following detection of a vaginal plug. A total of 34 mice received either the antisense or the control missense oligonucleotide.
At day 9 of pregnancy, mice were killed and the uteri examined for implantation sites. The average number of implantation sites was 13.3 in 13 mice transfected with the control missense oligonucleotide and 6.5 in the 20 mice transfected with the antisense oligonucleotide ( Figure 4) . A two-tailed unpaired t test demonstrated a significant difference between the average number of implantation sites in the two groups (P = 0.00002). In the 30 mice treated with the Hoxa10 antisense oligonucleotide, there was no significant difference between the number of implantation sites seen at day 9 in 18 mice and live births in 12 mice.
The endometrium appeared normal histologically, demonstrating adequate decidualization. Pups of mice transfected with Hoxa10 antisense were born following a normal length gestation of 17-20 days, were of normal size and demonstrated no morphological abnormalities. Male and female pups of mice transfected with the Hoxa10 antisense oligonucleotide mated with wild-type mice and demonstrated normal fertility and litter size.
Transfection of mouse endometrium with pcDNA3.1(+)/HOXA10 increases live birth rates To increase adult expression of Hoxa10, the endometrium of day 2 pregnant mice were transfected with either pcDNA3.1(+)/HOXA10 or pcDNA3.1(+) as a control. At day 9 of pregnancy, there was no significant difference between the average number of implantation sites in mice transfected with pcDNA3.1(+)/HOXA10 compared with controls transfected with pcDNA3.1(+) (data not shown). However, live birth rates did vary. Litter size ranged from 0 to 13 in nine pcDNA3.1(+) transfected controls whereas the 10 mice transfected with pcDNA3.1(+)/HOXA10 gave birth to between 11 and 14 pups ( Figure 5 ). The HOXA10-treated mice gave birth to larger litters with less variability than the controls. The difference between the average litter size in each group was demonstrated to be significant using a two-tailed unpaired t test (P = 0.024).
The implantation sites appeared histologically normal. There was no significant difference in placental weights or vasculature. Pups of mice transfected with pcDNA3.1(+)/HOXA10 were born following a normal length gestation of 17-20 days, were of normal size and demonstrated no morphological abnormalities. Male and female pups of mice transfected with pcDNA3.1(+) HOXA10 mated with wild-type mice and demonstrated normal fertility and litter size. Gene Therapy
Discussion
The role of Hox genes in embryonic development is wellestablished. [2] [3] [4] However, the functions of Hox genes in the adult are poorly characterized. Based on this paradigm, Hoxa10 was presumed to function during the embryogenesis of the reproductive tract. 6 However, indirect evidence has suggested a role for maternal Hoxa10 expression in implantation. 10, 14 We have previously shown that four genes of the HOXA cluster demonstrate continued expression in the adult reproductive tract. 5 Furthermore, we have shown that HOXA10 is expressed in the adult endometrium in a dynamic way that varies with the menstrual cycle suggesting a role for maternal HOXA10 in implantation. 7 Our present work shows that maternal expression of Hoxa10 in the endometrium of mice is essential for optimal implantation. This is the first report of the maternal alteration of a gene known to affect specifically implantation. When mouse endometrium is transfected with a Hoxa10 antisense oligonucleotide at the time of implantation, the number of embryos which implant in the uterus are significantly reduced compared with controls. The significant decrease in implantation sites in a uterus transfected with a Hoxa10 antisense oligonucleotide demonstrates that, in the background of normal embryonic Hoxa10, optimal implantation requires maternal Hoxa10 expression.
Fertility in mice can also be affected by increasing Hoxa10 expression. When mouse endometrium is transfected with HOXA10 cDNA, live birth rates increase compared with controls, despite the fact that implantation rates are unaltered. ␤-Galactosidase activity can still be detected on day 18 of pregnancy following liposomemediated gene transfection with pcDNA3.1(+)/LacZ, suggesting that Hoxa10 expression from pcDNA3.1(+)/HOXA10 is likely to be present in the endometrium of pregnant mice at least until parturition. The continued expression of increased levels of Hoxa10 in the pregnant uterus may improve placentation and hence optimize the ability of each implanted embryo to survive to term. While litter size is limited by the number of oocytes produced, consistently larger litters are seen with increased Hoxa10 expression; embryo loss may be a major determinant of litter size in controls. We have identified a novel role of Hoxa10 in the maintenance of pregnancy.
We expected that the transfection of the uterine lumen approximately 24 h before the embryo entered the uterine horns would result in an effect on the endometrium and not the embryo directly. Supporting this, pups of mice transfected with either a Hoxa10 antisense oligonucleotide or pcDNA3.1(+)/HOXA10 were born following a normal length gestation of 17-20 days. Pups were of normal size, demonstrated no morphological abnormalities and the placentas from both groups were normal. Male and female pups from both groups mated with wild-type mice. These matings resulted in viable offspring and normal litter size. Taken together, this demonstrates that the effect on pregnancy rates following injection of DNA/liposome complexes into the uterine lumen is probably due to the specific effect of gene transfection of the endometrium only and not an effect on the embryo. Few tissues have been identified which demonstrate persistent Hox gene expression in the adult. [15] [16] [17] [18] [19] [20] Adult Hox gene expression has been shown to occur in tissues which continue to differentiate in the adult. The role of Hox genes in the structural and functional differentiation of adult tissues is probably analogous to that in embryonic developmental processes. The endometrium undergoes complex structural and functional changes during each menstrual cycle in preparation for implantation and subsequent pregnancy. The alteration of maternal expression patterns of Hoxa10 affecting the function of the endometrium provides further evidence that adult Hox gene expression is important in tissues that undergo continued differentiation past the embryonic period. It is probable that the persistent expression of Hoxa10 in the adult enables the endometrium to retain developmental plasticity and allows the sequential differentiation of the endometrium during each menstrual cycle.
The liposome-mediated gene transfection techniques used in this work have identified the functional importance of maternal expression of Hoxa10 in the endometrium. This type of gene transfection allows the alteration of adult gene expression against a background of normal embryonic gene expression. In vivo gene transfection techniques are a potential means to distinguish between the effects of embryonic and adult gene expression on tissue-specific phenotypes. Furthermore, targeted mutations in mice often reduce viability and hence limit experimentation. Gene transfection in the adult is a method that selectively alters gene expression in the tissues of interest and circumvents effects on other tissues that are potentially lethal.
Differential cellular transfection also enables cellspecific gene function to be identified. In this study, we transfected nearly 100% of epithelial glandular cells but only 10% of stromal cells. The glandular expression of Hoxa10 is therefore more likely to be necessary for implantation. Endometrial glandular growth is estrogen dependent, yet glandular estrogen receptors are downregulated and undetectable at the time of implantation. 21 Inductive stromal-epithelial interactions regulate endometrial growth and differentiation leading to endometrial receptivity. 22 Estrogen presumably stimulates endometrial glandular development via a paracrine mechanism acting through the stromal estrogen receptor. This suggests that glandular Hoxa10 may be one target of paracrine regulation by endometrial stroma. The molecular nature of this mechanism remains to be elucidated.
As a model of human endometrium, we transfected Ishikawa cells, a well differentiated human endometrial adenocarcinoma cell line, with identical constructs to those used in mice. The anti-sense oligonucleotide was complementary to a region conserved in mouse and human Hoxa10/HOXA10. The expression of HOXA10 in Ishikawa cells is well characterized and provides an accurate representation of HOXA10 expression in the human endometrium in vivo. 7 We demonstrated that the constructs that transfect murine endometrium and alter fertility have the ability to alter HOXA10 expression in a human endometrial cell line.
We have previously shown that in the female reproductive tract, Hox gene expression patterns are identical between mouse and human. 5 In view of the necessary role of maternal Hoxa10 expression in mouse implantation, it is likely that the menstrual cycle-specific expression pattern of HOXA10 in women is similarly required for implantation. Genetic manipulation in humans using gene transfection is a developing technique, which has wide reaching therapeutic potential. Furthermore, cationic liposomes have been shown to be an effective and efficient method for delivery of genetic material to human tissue in vivo. 23, 24 Similar gene transfection techniques in human endometrium designed to manipulate HOXA10 expression may allow improved control of human implantation and reproduction. Manipulation of human expression patterns of HOXA10 in the adult endometrium may have potential as a contraceptive or fertility treatment.
Materials and methods
Plasmid constructs HOXA10 cDNA (a generous gift from C Largman, University of California, CA, USA) was cloned into the EcoRI site of pcDNA3.1(+) (Invitrogen, Carlsbad, CA, USA). pcDNA3.1(+) without the HOXA10 insert and pcDNA3.1(+)/LacZ were used as controls (Invitrogen).
Oligonucleotide design
Two 30 mer phosphothiorate oligodeoxyribonucleotides were synthesized at the WM Keck Oligonucleotide Laboratory at Yale University; one complementary to the start of translation of Hoxa10/HOXA10 corresponding to nucleotides 44-73 (GenBank accession number L08757), 5Ј-CTCTCCGAGCATGACATTGTTGTGGGATAA-3Ј, 25 the other with the same nucleotide composition but a random sequence was used as a control, 5Ј-TGCTGCTAG-GATCGTTCAAGTGTATCACGA-3Ј.
DNA/liposome preparation
For in vitro use, 12 l DNA was mixed with 300 l Opti-MEM Reduced Serum Medium (Life Technologies, Gaithersburg, MD, USA), added to 30 l of 22°C liposome (a 3:1 (w/w) formulation of 2,3-dioleyloxy-N-[2 (sperminecaboxamido)ethyl]-N-N-dimethyl-1-propanaminium trifluoroacetate (DOPSA) and dioleoylphosphatidyl ethanolamine (DOPE) (Life Technologies) in 300 l 37°C Opti-MEM and incubated for 45 min at room temperature. A final concentration of 4 g/ml DNA and 20 g/ml liposome was obtained by dilution with Opti-MEM to a total volume of 3 ml.
For in vivo use, 2 l of DNA was mixed with 10 l of liposome and incubated for 15 min at room temperature. A final concentration of 16 g/ml DNA and 40 g/ml liposome was obtained by dilution with 1× Dulbecco's phosphate-buffered saline (PBS) (Life Technologies) to a total volume of 100 l.
These concentrations were determined in vitro by optimization of the repression of HOXA10 protein expression which was determined by dose response experiments. Initially, 0-20 g of DNA solution was used and 0-50 l of liposome. Western analysis was used to determine optimal HOXA10 repression.
Ishikawa cell transfection
Ishikawa cells, a well differentiated human endometrial adenocarcinoma cell line 11, 12, 26, 27 (a generous gift from R Hochberg, Yale University, New Haven, CT, USA) were grown to 80% confluence in Minimum Essential Media with Earles Salts and l-glutamine (MEM) (Life Technologies), 10% fetal bovine serum, 1% sodium pyruvate, 1% penicillin and 1% streptomycin. A 25 cm 2 cellular monolayer was transfected with 3 ml of a DNA/liposome complex for 5 h, washed in PBS and maintained in MEM as above, for an additional 19 h. For RNA extraction, cells were lysed in 1 ml Trizol (Life Technologies). For protein extraction, cells were lysed with 0.5 ml chilled (0°C) single detergent lysis buffer (5 mm TrisCl (pH 8.0), 150 mm NaCl, 0.02% sodium azide, 100 g/ml PMSF, 1 g leupeptin, 1% Triton X-100). For X-gal staining, cells were fixed with 3 ml 2% formaldehyde, 0.2% glutaraldehyde in PBS at room temperature.
Probe preparation A 128 bp sequence of the 3Ј untranslated region of HOXA10 was cloned into the EcoRI and BamHI sites of pGEM3-Z (Promega, Madison, WI, USA). The construct was linearized with HindIII, ethanol precipitated and used as a template for riboprobe synthesis. Radiolabeled RNA probes were produced by in vitro transcription using a riboprobe kit (Promega), T7-RNA polymerase, and 32 P UTP (Amersham, Arlington Heights, II, USA). A human 1.1 kb glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA template (Clontech, Palo Alto, CA, USA) was used to generate a control probe by in vitro transcription as above.
Northern blot analysis Ishikawa cells that had been transfected with a DNA/liposome complex containing either a Hoxa10 antisense oligonucleotide or pcDNA3.1(+)/HOXA10 were homogenized with 3 ml Trizol. Total RNA was extracted and size fractionated on a 1% agarose/0.66 M formaldehyde gel and transferred to a nylon membrane. Membranes were hybridized with a 32 P-labeled HOXA10 riboprobe. Hybridization was performed overnight at 60°C in 50% formamide, 1 × SSC, 5 × Denhardt's solution and 0.2% tRNA using 2 × 10 6 c.p.m./ml of the 32 P-labeled HOXA10 riboprobe. The membrane was washed twice at 68°C for 30 min in 0.1 × SSC and 0.1% SDS. X-Omat AR film (Eastman Kodak, Rochester, NY, USA) was exposed overnight at −70°C. The autoradiographic bands were quantified using densitometry. Each HOXA10 band was normalized to the value obtained from the same lane hybridized with G3PDH.
Western blot analysis
Ishikawa cells, transfected as above, were lysed in single detergent lysis buffer and centrifuged at 12 000 g for 2 min at 4°C. The supernatant was loaded on to a 6% SDS polyacrylamide gel, size fractioned and transferred to a nitrocellulose membrane. The membrane was immersed in a 3% gelatin-Tris buffered saline (TBS) (20 mm Tris, 500 mm NaCl) blocking solution for 30 min at room temperature, washed for 10 min in TBS (20 mm Tris, 500 mm NaCl, 0.05% Tween-20, pH 7.5) and then incubated for 1 h with a 1:1000 dilution of HOXA10 polyclonal antibody (BabCo, Richmond, CA, USA). The membrane was washed with TBS for 5 min at room temperature and incubated for 1 h with a 1:200 dilution of goat anti-mouse IgG-HRP (BioRad, Hercules, CA, USA). The membrane was then washed 2 × in TBS for 5 min at room temperature and immersed in a horseradish peroxidase color developer buffer (BioRad) for 30 min. Photographs were taken immediately following color development.
Gene Therapy
In vivo gene transfection Nulliparous reproductive age female and male CD1 mice were obtained from Charles River (Wilmington, MA, USA). Female mice were mated and examined every 8 h until detection of a vaginal plug. The presence of a vaginal plug was designated day 1 of pregnancy. The mice were anesthetized 30-60 h following plug detection with 250 l of a 5% xylazine/10% ketamine mixture given by intraperitoneal injection. A laparotomy was performed to expose the uterus and 25 l of the DNA/liposome complex was injected into the base of each uterine horn using a 27-gauge needle. 28 The incision was closed in two layers (peritoneal and cutaneous) with 4-0 vicryl suture. These experiments were conducted in accordance with an approved protocol issued by the Yale Animal Care and Use Committee.
Localization of LacZ
Female mice which received pcDNA3.1(+)/LacZ were killed on day 4 of pregnancy, uteri removed, fixed in 1.25% glutaraldehyde in 20 ml PBS for 30 min, rinsed twice in 20 ml PBS and placed in X-gal staining solution (PBS containing 2 mm MgCl 2 , 0.02% NP-40, 0.01% sodium deoxylate, 5 mm K 3 Fe (CN) 6, 5 mm K4 (CN) 6 and 1 mg/ml X-gal) for 24 h at room temperature. Tissue was embedded in paraffin, sections obtained and examined by light microscopy.
Fixed Ishikawa cells that had been transfected with pcDNA3.1(+)/LacZ were washed three times with 5 ml PBS and stained with 2 ml of ␤-gal staining solution (Boehringer Mannheim, Indianapolis, IN, USA) for 1 h at 37°C. The cells were examined by light microscopy.
Embryo detection
Pregnant mice were either killed by cervical dislocation on day 9 of pregnancy or delivered at term. The uterus of each mouse killed on day 9 was dissected from the abdomen and the implantation sites counted using a dissecting microscope. At term, the numbers of pups born were counted on the day of parturition.
